UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Discovery of Novel Agonists and Antagonists of the Free Fatty Acid Receptor 1 (FFAR1) Using Virtual Screening

Journal of medicinal chemistry, 2008-02, Vol.51 (3), p.625-633

2008

Volltextzugriff (PDF)

Identification of Residues Important for Agonist Recognition and Activation in GPR40

The Journal of biological chemistry, 2007-10, Vol.282 (40), p.29248-29255

2007

Volltextzugriff (PDF)

Bidirectional, Iterative Approach to the Structural Delineation of the Functional “Chemoprint” in GPR40 for Agonist Recognition

Journal of medicinal chemistry, 2007-06, Vol.50 (13), p.2981-2989

2007

Volltextzugriff (PDF)

An optimized agonist peptide of protease-activated receptor 4 and its use in a validated platelet-aggregation assay

Platelets (Edinburgh), 2022-10, Vol.33 (7), p.979-986

2022

Volltextzugriff (PDF)

Two Arginine-Glutamate Ionic Locks Near the Extracellular Surface of FFAR1 Gate Receptor Activation

The Journal of biological chemistry, 2009-02, Vol.284 (6), p.3529-3536

2009

Volltextzugriff (PDF)

Cholesterol as a determinant of cooperativity in the M2 muscarinic cholinergic receptor

Biochemical pharmacology, 2007-07, Vol.74 (2), p.236-255

2007

Volltextzugriff (PDF)

Abstract 1869: Novel TNFR2 antibodies to overcome T cell exhaustion and suppressive tumor microenvironment

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1869-1869

2021

Volltextzugriff (PDF)

Potentiation of purinergic transmission by angiotensin in prostatic rat vas deferens

British journal of pharmacology, 1996-07, Vol.118 (6), p.1523-1529

1996

Volltextzugriff (PDF)

Nature of the oligomers formed by muscarinic m2 acetylcholine receptors in Sf9 cells

European journal of pharmacology, 2001-06, Vol.421 (1), p.11-22

2001

Volltextzugriff (PDF)

Effects of N-Ethylmaleimide on Conformational Equilibria in Purified Cardiac Muscarinic Receptors

The Journal of biological chemistry, 2002-09, Vol.277 (39), p.36188-36203

2002

Volltextzugriff (PDF)

Apparent capacity of cardiac muscarinic receptors for different radiolabeled antagonists

Biochemical pharmacology, 2001-10, Vol.62 (7), p.829-851

2001

Volltextzugriff (PDF)

GPCR profiling: from hits to leads and from genotype to phenotype

Drug discovery today. Technologies, 2015-11, Vol.18, p.30-37

2015

Volltextzugriff (PDF)

Synthesis and SAR of 1,2,3,4-Tetrahydroisoquinoline-Based CXCR4 Antagonists

ACS medicinal chemistry letters, 2018-01, Vol.9 (1), p.17-22

2018

Volltextzugriff (PDF)

Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors

The Journal of pharmacology and experimental therapeutics, 2016-02, Vol.356 (2), p.293

2016

Volltextzugriff (PDF)

Cholesterol as a determinant of cooperativity in the M 2 muscarinic cholinergic receptor

Biochemical pharmacology, 2007-07, Vol.74 (2), p.236-255

2007

Volltextzugriff (PDF)

Two Arginine-Glutamate Ionic Locks Near the Extracellular Surface of FFAR1 Gate Receptor ActivationS

The Journal of biological chemistry, 2009-02, Vol.284 (6), p.3529-3536

2009

Volltextzugriff (PDF)

Discovery of novel agonists and antagonists of the free fatty acid receptor one (FFAR1) using virtual screening

Journal of medicinal chemistry, 2008-01, Vol.51 (3), p.625-633

2008

Volltextzugriff (PDF)

Transactivation of PDGFR[beta] by dopamine D4 receptor does not require PDGFR[beta] dimerization

Molecular brain, 2010-07, Vol.3, p.22

2010

Volltextzugriff (PDF)

A bi-directional, iterative approach to the structural delineation of the functional “chemoprint” in GPR40 for agonist recognition

Journal of medicinal chemistry, 2007-06, Vol.50 (13), p.2981-2989

2007

Volltextzugriff (PDF)

Transactivation of PDGFRβ by dopamine D4 receptor does not require PDGFRβ dimerization

Molecular brain, 2010-07, Vol.3 (1), p.22-22, Article 22

2010

Volltextzugriff (PDF)

Cooperativity and Oligomeric Status of Cardiac Muscarinic Cholinergic Receptors

Biochemistry (Easton), 2002-04, Vol.41 (17), p.5588-5604

2002

Volltextzugriff (PDF)

Transactivation of PDGFRbeta by dopamine D4 receptor does not require PDGFRbeta dimerization

Molecular brain, 2010-07, Vol.3, p.22

2010

Volltextzugriff (PDF)

Apparent capacity of cardiac muscarinic receptors for different radiolabeled antagonists 6 6Abbreviations: ABT, 3-(2′-aminobenzhydryloxy)tropane; ECL, enhanced chemiluminescence; NMS, N-methylscopolamine; PMSF, phenylmethylsulfonyl fluoride; and QNB, l-quinuclidinylbenzilate

Biochemical pharmacology, 2001-10, Vol.62 (7), p.829-851

2001

Volltextzugriff (PDF)

Erratum to “Nature of the oligomers formed by muscarinic m2 acetylcholine receptors in Sf9 cells” [Eur. J. Pharmacol. 421 (2001) 11–22]

European journal of pharmacology, 2001-08, Vol.425 (3), p.239-239

2001

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(54)

Publikationsform

Sprache

Englisch
(59)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB*
(31)
Ingenta
(30)
MEDLINE
(29)
Journals@Ovid Ovid Full Text
(19)
IngentaConnect Journals
(14)
ScienceDirect
(14)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(9)
Standalone journals
(7)
Springer journals
(6)
Wiley-Blackwell Journals
(4)
Taylor & Francis Online
(3)
Access via Taylor & Francis
(3)
Taylor & Francis
(3)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(2)
Oxford Journals
(2)
Oxford Journals 2020 Medicine
(2)
Wiley Online Library
(2)
Nexis Uni
(2)
ERIC
(1)
PAIS Index
(1)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Discovery of Novel Agonists and Antagonists of the Free Fatty Acid Receptor 1 (FFAR1) Using Virtual Screening

Identification of Residues Important for Agonist Recognition and Activation in GPR40

Bidirectional, Iterative Approach to the Structural Delineation of the Functional “Chemoprint” in GPR40 for Agonist Recognition

An optimized agonist peptide of protease-activated receptor 4 and its use in a validated platelet-aggregation assay

Two Arginine-Glutamate Ionic Locks Near the Extracellular Surface of FFAR1 Gate Receptor Activation

Cholesterol as a determinant of cooperativity in the M2 muscarinic cholinergic receptor

Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4

Abstract 1869: Novel TNFR2 antibodies to overcome T cell exhaustion and suppressive tumor microenvironment

Potentiation of purinergic transmission by angiotensin in prostatic rat vas deferens

Nature of the oligomers formed by muscarinic m2 acetylcholine receptors in Sf9 cells

Effects of N-Ethylmaleimide on Conformational Equilibria in Purified Cardiac Muscarinic Receptors

Apparent capacity of cardiac muscarinic receptors for different radiolabeled antagonists

GPCR profiling: from hits to leads and from genotype to phenotype

Synthesis and SAR of 1,2,3,4-Tetrahydroisoquinoline-Based CXCR4 Antagonists

Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors

Cholesterol as a determinant of cooperativity in the M 2 muscarinic cholinergic receptor

Two Arginine-Glutamate Ionic Locks Near the Extracellular Surface of FFAR1 Gate Receptor ActivationS

Discovery of novel agonists and antagonists of the free fatty acid receptor one (FFAR1) using virtual screening

Transactivation of PDGFR[beta] by dopamine D4 receptor does not require PDGFR[beta] dimerization

A bi-directional, iterative approach to the structural delineation of the functional “chemoprint” in GPR40 for agonist recognition

Transactivation of PDGFRβ by dopamine D4 receptor does not require PDGFRβ dimerization

Cooperativity and Oligomeric Status of Cardiac Muscarinic Cholinergic Receptors

Transactivation of PDGFRbeta by dopamine D4 receptor does not require PDGFRbeta dimerization

Apparent capacity of cardiac muscarinic receptors for different radiolabeled antagonists 6 6Abbreviations: ABT, 3-(2′-aminobenzhydryloxy)tropane; ECL, enhanced chemiluminescence; NMS, N-methylscopolamine; PMSF, phenylmethylsulfonyl fluoride; and QNB, l-quinuclidinylbenzilate

Erratum to “Nature of the oligomers formed by muscarinic m2 acetylcholine receptors in Sf9 cells” [Eur. J. Pharmacol. 421 (2001) 11–22]

Suchergebnisse filtern